| Fiona Kay, LCSW-C | |
|
201 Peach Blossom Rd, Easton, MD 21601-2544 | |
| (410) 763-9635 | |
| (833) 914-0415 |
| Full Name | Fiona Kay |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 201 Peach Blossom Rd, Easton, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134708779 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 24841 (Maryland) | Primary |
| Entity Name | Choptank Community Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356388599 PECOS PAC ID: 0648189274 Enrollment ID: O20040128000303 |
News Archive
Although syphilis is one of the oldest known diseases, most health professionals do not have access to the tests necessary to reliably diagnose it in its earliest and most infectious stage. A recent survey of infectious diseases specialists regarding the diagnosis and treatment of syphilis appears in the November 15, 2009 issue of Clinical Infectious Diseases, now available online.
Covagen today announced it has initiated a Phase Ib/IIa study with COVA322, a bispecific TNF/IL-17A inhibitor.
Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and MonoSol Rx, the leader in developing and manufacturing pharmaceutical films based on its proprietary PharmFilm drug delivery technology, today announced the filing of a provisional US patent application for "Nanoparticle Film Delivery Systems." The applications submitted to the United States Patent and Trademark Office (USPTO) relate to therapeutic uses of nanoparticle-based proteins and peptides delivered in pharmaceutical films.
Results from the Phase 2 RESONATE-17 (PCYC-1117) study show IMBRUVICA (ibrutinib) was associated with an 82.6 percent investigator-assessed overall response rate (ORR; the primary endpoint) and a 79 percent progression-free survival (PFS) rate at 12 months in people living with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have a genetic mutation known as deletion 17p (del 17p).
University of Florida urologists have used robot-assisted surgery to cut about 20 minutes off average surgery time for conventional vasectomy reversal using a microscope.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fiona Kay, LCSW-C 201 Peach Blossom Rd, Easton, MD 21601-2544 Ph: (410) 763-9635 | Fiona Kay, LCSW-C 201 Peach Blossom Rd, Easton, MD 21601-2544 Ph: (410) 763-9635 |
News Archive
Although syphilis is one of the oldest known diseases, most health professionals do not have access to the tests necessary to reliably diagnose it in its earliest and most infectious stage. A recent survey of infectious diseases specialists regarding the diagnosis and treatment of syphilis appears in the November 15, 2009 issue of Clinical Infectious Diseases, now available online.
Covagen today announced it has initiated a Phase Ib/IIa study with COVA322, a bispecific TNF/IL-17A inhibitor.
Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and MonoSol Rx, the leader in developing and manufacturing pharmaceutical films based on its proprietary PharmFilm drug delivery technology, today announced the filing of a provisional US patent application for "Nanoparticle Film Delivery Systems." The applications submitted to the United States Patent and Trademark Office (USPTO) relate to therapeutic uses of nanoparticle-based proteins and peptides delivered in pharmaceutical films.
Results from the Phase 2 RESONATE-17 (PCYC-1117) study show IMBRUVICA (ibrutinib) was associated with an 82.6 percent investigator-assessed overall response rate (ORR; the primary endpoint) and a 79 percent progression-free survival (PFS) rate at 12 months in people living with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have a genetic mutation known as deletion 17p (del 17p).
University of Florida urologists have used robot-assisted surgery to cut about 20 minutes off average surgery time for conventional vasectomy reversal using a microscope.
› Verified 1 days ago
Paul J Washo, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 29520 Canvasback Dr, Easton, MD 21601 Phone: 410-822-5007 | |
Ms. Christina P Morris, LICENSED CLINICAL SO Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Talbot St, Easton, MD 21601 Phone: 410-822-1018 Fax: 410-820-5884 | |
Jennifer L Fitzpatrick, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Talbot Street, Easton, MD 21601 Phone: 410-822-1018 Fax: 410-820-5884 | |
Elizabeth Chatham, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 300 Talbot St, Easton, MD 21601 Phone: 410-822-1018 | |
Kira Ashley Gillin, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29512 Canvasback Dr, Easton, MD 21601 Phone: 630-835-6550 | |
Emma Ikharo, LCPC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29466 Pintail Dr, Ste 9, Easton, MD 21601 Phone: 410-770-5140 Fax: 410-770-5141 | |
Norma L. Trax, MED, MSW, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8571 Black Dog Aly, Easton, MD 21601 Phone: 410-991-3395 |